About Excell Research

Our Values
At Excell Research, we are committed to:
• Delivering timely and accurate data that fosters the drug development process
• Providing patients and their families with a compassionate, supportive research environment
• Upholding scientific and ethical integrity
• Educating our team members in the latest medical advances

Our Team

Jelena Kunovac, M.D., M.S.
In addition, she is an Adjunct Assistant Professor of Psychiatry at the University of Nevada, Las Vegas. Dr. Kunovac regularly authors scientific publications in respected medical journals and presents her research at scientific meetings around the world.
Dr. Kunovac is Board Certified in Psychiatry. She completed Residency Training in Psychiatry at the University of California, San Diego (UCSD). While at UCSD, Dr. Kunovac was a NIMH fellow. Previously, she received a Master’s Degree in Biological Psychiatry and an M.D. from the University Of Belgrade School Of Medicine where she graduated as the Valedictorian of her class.
As a former TV talk show host in her native Yugoslavia, Dr Kunovac is in great demand as a public speaker, and travels all over the world teaching and lecturing doctors and other health care professionals on advances in the field.

Sherry Soefje, M.D.
Over the past 30 years, Dr. Soefje has dedicated her time and efforts to people and families affected by mental illnesses through helping advance the development of new treatments.
Our Experience
Excell Research: Areas of Study
Central Nervous System Disorder Studies:
Alzheimer’s Disease
Attention Deficit Hyperactive Disorder
Bipolar Disorder
General Anxiety Disorder
Insomnia
Major Depressive Disorder
Mild Cognitive Impairment
Obsessive-Compulsive Disorder
Post-Traumatic Stress Disorder
Postpartum Depression
Schizophrenia
Women’s Health Studies:
Endometriosis
Hypoactive Sexual Desire Disorder
Polycystic Ovarian Syndrome
Uterine Fibroids
General Medical Health Studies:
Chronic Idiopathic Constipation
Essential Tremors
Fibromyalgia
Migraines
Opioid Induced Constipation
Tardive Dyskinesia
Excell Research may be seeking participants for an upcoming clinical research study for an area or disease that is relevant to you or someone you know.
Partner Pharmaceutical Companies and Researchers
• Abbott
• ACADIA
• AgeneBio
• Alder Biopharmaceuticals
• Alkermes
• Allergan
• Amarex
• Amgen
• Aptinyx
• Astellas
• Avanir Pharmaceuticals
• Axsome Therapeutics
• Bionomics
• Biogen Pharmaceuticals
• Braintree Laboratories, Inc.
• CeNeRx
• Cerecor
• Chiltern
• Clexio
• Corcept
• Daiichi Sankyo Pharma Development
• Edgemont Pharmaceuticals, Inc.
• Eisai
• EnVivo
• Evidara
• Evotec
• Fanapt
• Forest Pharmaceuticals
• Impel NeuroPharma
• Janssen
• JAZZ Pharmaceuticals, Inc.
• Lilly
• Lundbeck
• Marinus
• MediVector
• Merck Corporation
• Millendo Therapeutics, Inc.
• Methylation Sciences, Inc.
• Myovant
• Nektar
• Neurocrine Biosciences
• Novartis
• Ogeda
• Otsuka Pharmaceuticals
• Palatin Technologies, Inc.
• Pfizer
• Pharmascience, Inc.
• Reckitt Benckiser Pharmaceuticals, Inc.
• Rexahn Pharmaceuticals
• Roche
• Sage
• Schering-Plough
• Sepracor
• Shionogi
• Swing Therapeutics
• Sunovion
• Takeda
• Targacept
• TauRx Therapeutics LTD
• TEVA
• Tonix
• University of Arizona
• University of Montana
• Vanda
• Wyeth
New Partner Pharmaceutical Companies and Researchers 2022
- Biohaven Pharmaceuticals
- GATE
- GW Research
- Karuna Therapeutics
- Lundbeck
- Neurocrine
- Praxis
- Relmada
- Virios
- Vistagen